Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000425113

Medchemexpress LLC aStAx-35R TFA | 99.1% | 2392.86 | 1 MG
SDP

Catalog No. 5000425113
Encompass_Preferred

aStAx-35R TFA is a stapled peptide that functions as an antagonist of the nuclear form of β-catenin, thereby inhibiting Wnt signaling. It competitively prevents the binding of β-catenin to TCF4 and selectively induces growth inhibition in Wnt-dependent cancer cells.

  • Directly targets and antagonizes the nuclear form of β-catenin.
  • Effectively inhibits the Wnt signaling pathway.
  • Competitively inhibits the binding of β-catenin to TCF4.
  • Selectively induces growth inhibition in cancer cells dependent on Wnt signaling.

Catalog No. 50-004-25113 Supplier Medchemexpress LLC Supplier No. HYP10392B1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

aStAx-35R TFA is a stapled peptide that functions as an antagonist of the nuclear form of β-catenin, thereby inhibiting Wnt signaling. It competitively prevents the binding of β-catenin to TCF4 and selectively induces growth inhibition in Wnt-dependent cancer cells.

  • Directly targets and antagonizes the nuclear form of β-catenin.
  • Effectively inhibits the Wnt signaling pathway.
  • Competitively inhibits the binding of β-catenin to TCF4.
  • Selectively induces growth inhibition in cancer cells dependent on Wnt signaling.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.